表紙
市場調查報告書

照護現場 (POC) 檢驗的全球市場:產業分析,各地區的預測,應用開發可能性,價格趨勢,競爭市場佔有率,預測

Point of Care Testing Market Size By Product, By Technology, By Prescription, By Application, By End-use Industry Analysis Report, Regional Outlook, Application Development Potential, Price Trends, Competitive Market Share & Forecast, 2018 - 2024

出版商 Global Market Insights Inc. 商品編碼 786049
出版日期 內容資訊 英文 385 Pages
商品交期: 2-3個工作天內
價格
Back to Top
照護現場 (POC) 檢驗的全球市場:產業分析,各地區的預測,應用開發可能性,價格趨勢,競爭市場佔有率,預測 Point of Care Testing Market Size By Product, By Technology, By Prescription, By Application, By End-use Industry Analysis Report, Regional Outlook, Application Development Potential, Price Trends, Competitive Market Share & Forecast, 2018 - 2024
出版日期: 2019年01月16日內容資訊: 英文 385 Pages
簡介

本報告提供全球照護現場 (POC) 檢驗市場相關調查分析,提供產業的考察,各市場區隔的市場分析,各地區的分析,主要企業等相關的系統性資訊。

第1章 調查手法

第2章 摘要整理

第3章 照護現場 (POC) 檢驗產業的考察

  • 產業區分
  • 產業形勢
  • 產業影響力
  • 成長潛力分析
  • 法規形勢
  • 技術形勢
  • 企業佔有率分析
  • 市場佔有率分析
  • 波特的五力分析
  • 競爭情形
  • PESTEL分析

第4章 照護現場 (POC) 檢驗市場:各產品

  • 市場佔有率
  • 血糖監測系統
  • 心血管代謝檢驗
  • 傳染病檢查
  • 血液凝固檢查
  • 妊娠·妊娠檢驗
  • 腫瘤/癌症標記檢驗
  • 尿液檢查
  • 膽固醇檢驗
  • 血液檢驗
  • 藥物濫用檢測
  • 大便潛血試驗
  • 其他

第5章 照護現場 (POC) 檢驗市場:各技術

  • 市場佔有率
  • 側流化驗
  • 試紙
  • 微流體
  • 分子診斷
  • 免疫檢測
  • 凝集反應
  • 流通量
  • 固相
  • 生物感應器

第6章 照護現場 (POC) 檢驗市場:各處方

  • 市場佔有率
  • OTC
  • 處方型

第7章 照護現場 (POC) 檢驗市場:各用途

  • 市場佔有率
  • 心臟代謝
  • 感染疾病
  • 腎臟病
  • 藥物濫用
  • 血糖
  • 妊娠
  • 癌症生物標記
  • 其他

第8章 照護現場 (POC) 檢驗市場:各最終用途

  • 市場佔有率
  • 醫院
  • 診斷中心
  • 研究所
  • 居家醫療
  • 其他

第9章 照護現場 (POC) 檢驗市場:各地區

  • 市場佔有率
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第10章 企業簡介

  • Abaxis, Inc.
  • Abbott Laboratories
  • Accubiotech Co, Ltd.
  • ACON Laboratories, Inc.
  • Alere Inc.
  • Becton, Dickinson and Company
  • Biolytical Laboratories
  • bioMrieux SA
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation (HemoCue)
  • Dexcom, Inc.
  • Dragerwerk Ag & Co.
  • Johnson & Johnson
  • Medtronic
  • Meridian Bioscience, Inc.
  • Nova Biomedical
  • Orasure Technologies, Inc.
  • Roche Diagnostic Corporation
  • Siemens Healthineers
  • Sysmex Corporation
  • Trinity Biotech
目錄
Product Code: 3086

Title:
Point of Care Testing Market Size By Product (Glucose Monitoring, Cardiometabolic Testing, Infectious Disease Testing, Coagulation Testing, Pregnancy and Fertility Testing, Tumour/Cancer Marker Testing, Urinalysis Testing, Cholesterol Testing, Haematology Testing, Drugs-of-Abuse Testing, Faecal Occult Testing), By Technology (Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics, Immunoassays, Agglutination Assays, Flow-Through, Solid Phase, Biosensors), By Prescription (OTC Testing, Prescription-Based Testing), By Application (Cardio Metabolic Testing, Infectious Disease Testing, Nephrology Testing, Drug-of-Abuse (DoA) Testing, Blood Glucose Testing, Pregnancy Testing, Cancer Biomarker Testing), By End-use (Hospitals, Diagnostic Centres, Research Laboratories, Home-Care Settings) Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, China, India, Japan, Australia, Brazil, Mexico, South Africa, Saudi Arabia), Application Development Potential, Price Trends, Competitive Market Share & Forecast, 2018 - 2024.

Point of Care Testing Market will exceed USD 34.2 billion by 2024; as per a new research report.

Rise in awareness regarding early disease diagnosis and prevention will boost the demand for point of care molecular diagnostics. Applications such as drug regimen selection, patient stratification, therapeutic monitoring, and detection of predisposition to disease will drive the market growth. Presently, target specific PCR method is used to screen disease causative pathogen. High accuracy level along with more reliability are major factors driving growth of point of care testing market.

High cost of point of care testing devices will be a market hindering factor. The high price of the test and the devices will be unaffordable for the people living in low and middle income countries. Hence, it will lead to decline in product adoption thereby, hampering market growth.

Hematology testing products market held a significant market share in the year 2017 and was valued around USD 2,382.1 million. Increase in prevalence of genetic bleeding disorders such as hemophilia will spur the industry growth. According to the National Hemophilia Foundation, the global prevalence of hemophilia is estimated to be more than 400,000 currently. Hence, rise in number of people suffering from blood disorders will lead to growing hematology testing, augmenting the market growth.

Dipsticks technology market is estimated to grow at a CAGR of 7.5% during the forecast timeframe. Modern automated urine dipstick analyzer provides necessary consistency in timing and color interpretation. Several applications of dipstick in identifying presence of bacterial infection, will drive the growth of dipsticks technology over the forecast period.

OTC testing market was valued around USD 12,403.4 million in the year 2017. The OTC-based tests do not require extensive space like clinical laboratories and its turnaround time is quick. Significant growth in home healthcare sector along with increase in demand and adoption rate of self-tests, especially in case of blood glucose monitoring will enhance the market growth.

The use of point of care testing devices in Drug-of-Abuse (DoA) testing is projected to grow at a CAGR of 7.1% during the forecast period. As per the National Survey on Drug Use and Health (NSDUH), more than 21.5 million Americans were addicted to drugs in the year 2014. Increase in number of people getting addicted drugs will ultimately boost the demand and adoption rate of DoA testing, thereby augmenting the industry growth.

The use of point of care testing in homecare settings was valued at around USD 5,276.2 million in the year 2017. High adoption of devices among the elderly population that are prone to chronic conditions along with reduced physician visits as well as availability of portable, user-friendly and accurate disease monitoring devices will augment the market growth.

UK point of care testing market is estimated to grow at a CAGR of 6.6% during the projection period. Increase in number of people suffering from infectious diseases along with recent technological advancements will drive the point of care testing market in the region.

Japan dominated the Asia Pacific point of care testing market and was valued around USD 843.7 million in the year 2017. Increase in adoption of homecare point of care testing devices and rise in awareness regarding rapid diagnostic testing will augment the point of care testing in the region.

Some of the notable players in point of care testing market participants include Abbott, F. Hoffmann-La Roche Ltd., Johnson and Johnson, Siemens AG, and Abaxis. The major strategy adopted by the key industry players include mergers, acquisitions, partnerships and collaborations. Also, product innovations and new product development will enhance the company's product portfolio giving them an upper hand among other major market players.

Table of Contents

Chapter 1. Methodology

  • 1.1. Methodology
  • 1.2. Market definition
  • 1.3. Forecast parameters
  • 1.4. Data sources
    • 1.4.1. Secondary
      • 1.4.1.1. Paid sources
      • 1.4.1.2. Unpaid sources
    • 1.4.2. Primary

Chapter 2. Executive Summary

  • 2.1. Point of care testing industry 360 degree synopsis, 2013 - 2024
    • 2.1.1. Business trends
    • 2.1.2. Product trends
    • 2.1.3. Technology trends
    • 2.1.4. Prescription trends
    • 2.1.5. Application trends
    • 2.1.6. End-use trends
    • 2.1.7. Regional trends

Chapter 3. Point of Care Testing Industry Insights

  • 3.1. Industry segmentation
  • 3.2. Industry landscape, 2013 - 2024
  • 3.3. Industry impact forces
    • 3.3.1. Growth drivers
      • 3.3.1.1. Upward trend in disease prevalence among developing countries such as India
      • 3.3.1.2. Surging number of pathology labs and services equipped with advanced diagnostic equipment in North America
      • 3.3.1.3. Technological advancements
      • 3.3.1.4. Increasing R&D investment
      • 3.3.1.5. Growing geriatric population base globally
    • 3.3.2. Industry pitfalls & challenges
      • 3.3.2.1. High cost of product development
  • 3.4. Growth potential analysis
    • 3.4.1. By product
    • 3.4.2. By technology
    • 3.4.3. By prescription
    • 3.4.4. By application
    • 3.4.5. By end-use
  • 3.5. Regulatory landscape
    • 3.5.1. U.S.
    • 3.5.2. Europe
  • 3.6. Technology landscape
  • 3.7. Company share analysis, 2017 (by region)
    • 3.7.1. Global market share analysis, 2017
    • 3.7.2. North America
    • 3.7.3. Europe
    • 3.7.4. Asia Pacific
    • 3.7.5. Latin America
    • 3.7.6. Middle East and Africa
  • 3.8. Global market share analysis, by settings and application, 2017
  • 3.9. Company's global market share analysis, by setting and application, 2017
    • 3.9.1. F. Hoffmann-La Roche Ltd
    • 3.9.2. Abbott
    • 3.9.3. Johnson and Johnson
    • 3.9.4. Siemens AG
    • 3.9.5. Abaxis
  • 3.10. Porter's analysis
  • 3.11. Competitive landscape, 2017
    • 3.11.1. Business overview
    • 3.11.2. Revenue analysis
    • 3.11.3. Product landscape
    • 3.11.4. Strategy dashboard
  • 3.12. PESTEL analysis

Chapter 4. Point of Care Testing Market, By Product

  • 4.1. Global point of care testing market share, by product, 2017 & 2024
  • 4.2. Glucose monitoring
    • 4.2.1. Market size, by region, 2013 - 2024 (USD Million)
    • 4.2.2. Strips
      • 4.2.2.1. Market size, by region, 2013 - 2024 (USD Million)
    • 4.2.3. Meters
      • 4.2.3.1. Market size, by region, 2013 - 2024 (USD Million)
    • 4.2.4. Lancets
      • 4.2.4.1. Market size, by region, 2013 - 2024 (USD Million)
  • 4.3. Cardiometabolic testing products
    • 4.3.1. Market size, by region, 2013 - 2024 (USD Million)
    • 4.3.2. Cardiac marker testing products
      • 4.3.2.1. Market size, by region, 2013 - 2024 (USD Million)
    • 4.3.3. Blood Gas/Electrolytes testing products
      • 4.3.3.1. Market size, by region, 2013 - 2024 (USD Million)
    • 4.3.4. HBA1C testing products
      • 4.3.4.1. Market size, by region, 2013 - 2024 (USD Million)
  • 4.4. Infectious disease testing products
    • 4.4.1. Market size, by region, 2013 - 2024 (USD Million)
    • 4.4.2. Influenza testing products
      • 4.4.2.1. Market size, by region, 2013 - 2024 (USD Million)
    • 4.4.3. HIV testing products
      • 4.4.3.1. Market size, by region, 2013 - 2024 (USD Million)
    • 4.4.4. Hepatitis C testing products
      • 4.4.4.1. Market size, by region, 2013 - 2024 (USD Million)
    • 4.4.5. Sexually Transmitted Disease (STD) testing products
      • 4.4.5.1. Market size, by region, 2013 - 2024 (USD Million)
    • 4.4.6. Healthcare-Associated Infection (HAI) testing products
      • 4.4.6.1. Market size, by region, 2013 - 2024 (USD Million)
    • 4.4.7. Respiratory infection testing products
      • 4.4.7.1. Market size, by region, 2013 - 2024 (USD Million)
    • 4.4.8. Tropical disease testing products
      • 4.4.8.1. Market size, by region, 2013 - 2024 (USD Million)
    • 4.4.9. Other infectious diseases testing products
      • 4.4.9.1. Market size, by region, 2013 - 2024 (USD Million)
  • 4.5. Coagulation testing products
    • 4.5.1. Market size, by region, 2013 - 2024 (USD Million)
    • 4.5.2. PT/INR testing products
      • 4.5.2.1. Market size, by region, 2013 - 2024 (USD Million)
    • 4.5.3. Activated Clotting Time (ACT/APTT) testing products
      • 4.5.3.1. Market size, by region, 2013 - 2024 (USD Million)
  • 4.6. Pregnancy and fertility testing products
    • 4.6.1. Market size, by region, 2013 - 2024 (USD Million)
    • 4.6.2. Pregnancy testing products
      • 4.6.2.1. Market size, by region, 2013 - 2024 (USD Million)
    • 4.6.3. Fertility testing products
      • 4.6.3.1. Market size, by region, 2013 - 2024 (USD Million)
  • 4.7. Tumor/Cancer marker testing products
    • 4.7.1. Market size, by region, 2013 - 2024 (USD Million)
  • 4.8. Urinalysis testing products
    • 4.8.1. Market size, by region, 2013 - 2024 (USD Million)
  • 4.9. Cholesterol testing products
    • 4.9.1. Market size, by region, 2013 - 2024 (USD Million)
  • 4.10. Hematology testing products
    • 4.10.1. Market size, by region, 2013 - 2024 (USD Million)
  • 4.11. Drug-of-Abuse (DoA) testing products
    • 4.11.1. Market size, by region, 2013 - 2024 (USD Million)
  • 4.12. Fecal occult testing products
    • 4.12.1. Market size, by region, 2013 - 2024 (USD Million)
  • 4.13. Other products
    • 4.13.1. Market size, by region, 2013 - 2024 (USD Million)

Chapter 5. Point of Care Market, By Technology

  • 5.1. Point of care market share by technology, 2017 & 2024
  • 5.2. Lateral flow assays
    • 5.2.1. Market size, by region, 2013 - 2024 (USD Million)
  • 5.3. Dipsticks
    • 5.3.1. Market size, by region, 2013 - 2024 (USD Million)
  • 5.4. Microfluidics
    • 5.4.1. Market size, by region, 2013 - 2024 (USD Million)
  • 5.5. Molecular diagnostics
    • 5.5.1. Market size, by region, 2013 - 2024 (USD Million)
  • 5.6. Immunoassays
    • 5.6.1. Market size, by region, 2013 - 2024 (USD Million)
  • 5.7. Agglutination assays
    • 5.7.1. Market size, by region, 2013 - 2024 (USD Million)
  • 5.8. Flow-Through
    • 5.8.1. Market size, by region, 2013 - 2024 (USD Million)
  • 5.9. Solid phase
    • 5.9.1. Market size, by region, 2013 - 2024 (USD Million)
  • 5.10. Biosensors
    • 5.10.1. Market size, by region, 2013 - 2024 (USD Million)

Chapter 6. Point of Care Market, By Prescription

  • 6.1. Point of care market share by prescription, 2017 & 2024
  • 6.2. OTC testing
    • 6.2.1. Market size, by region, 2013 - 2024 (USD Million)
  • 6.3. Prescription-based testing
    • 6.3.1. Market size, by region, 2013 - 2024 (USD Million)

Chapter 7. Point of Care Market, By Application

  • 7.1. Point of care market share by application, 2017 & 2024
  • 7.2. Cardio metabolic testing
    • 7.2.1. Market size, by region, 2013 - 2024 (USD Million)
  • 7.3. Infectious disease testing
    • 7.3.1. Market size, by region, 2013 - 2024 (USD Million)
  • 7.4. Nephrology testing
    • 7.4.1. Market size, by region, 2013 - 2024 (USD Million)
  • 7.5. Drug-of-Abuse (DoA) testing
    • 7.5.1. Market size, by region, 2013 - 2024 (USD Million)
  • 7.6. Blood glucose testing
    • 7.6.1. Market size, by region, 2013 - 2024 (USD Million)
  • 7.7. Pregnancy testing
    • 7.7.1. Market size, by region, 2013 - 2024 (USD Million)
  • 7.8. Cancer biomarker testing
    • 7.8.1. Market size, by region, 2013 - 2024 (USD Million)
  • 7.9. Other applications
    • 7.9.1. Market size, by region, 2013 - 2024 (USD Million)

Chapter 8. Point of Care Market, By End-use

  • 8.1. Point of care market share by end-use, 2017 & 2024
  • 8.2. Hospitals
    • 8.2.1. Market size, by region, 2013 - 2024 (USD Million)
  • 8.3. Diagnostic centers
    • 8.3.1. Market size, by region, 2013 - 2024 (USD Million)
  • 8.4. Research laboratories
    • 8.4.1. Market size, by region, 2013 - 2024 (USD Million)
  • 8.5. Home-care settings
    • 8.5.1. Market size, by region, 2013 - 2024 (USD Million)
  • 8.6. Other end-uses
  • 8.7. Market size, by region, 2013 - 2024 (USD Million)

Chapter 9. Point of Care Market, By Region

  • 9.1. Point of care market share by region, 2017 & 2024
  • 9.2. North America
    • 9.2.1. Market size, by country, 2013 - 2024 (USD Million)
    • 9.2.2. Market size, by product, 2013 - 2024 (USD Million)
      • 9.2.2.1. Market size, by glucose monitoring, 2013 - 2024 (USD Million)
      • 9.2.2.2. Market size, by cardiometabolic testing products, 2013 - 2024 (USD Million)
      • 9.2.2.3. Market size, by infectious disease testing products, 2013 - 2024 (USD Million)
      • 9.2.2.4. Market size, by coagulation testing products, 2013 - 2024 (USD Million)
      • 9.2.2.5. Market size, by pregnancy and fertility testing products, 2013 - 2024 (USD Million)
    • 9.2.3. Market size, by technology, 2013 - 2024 (USD Million)
    • 9.2.4. Market size, by prescription, 2013 - 2024 (USD Million)
    • 9.2.5. Market size, by application, 2013 - 2024 (USD Million)
    • 9.2.6. Market size, by end-use, 2013 - 2024 (USD Million)
    • 9.2.7. U.S.
      • 9.2.7.1. Market size, by product, 2013 - 2024 (USD Million)
        • 9.2.7.1.1. Market size, by glucose monitoring, 2013 - 2024 (USD Million)
        • 9.2.7.1.2. Market size, by cardiometabolic testing products, 2013 - 2024 (USD Million)
        • 9.2.7.1.3. Market size, by infectious disease testing products, 2013 - 2024 (USD Million)
        • 9.2.7.1.4. Market size, by coagulation testing products, 2013 - 2024 (USD Million)
        • 9.2.7.1.5. Market size, by pregnancy and fertility testing products, 2013 - 2024 (USD Million)
      • 9.2.7.2. Market size, by technology, 2013 - 2024 (USD Million)
      • 9.2.7.3. Market size, by prescription, 2013 - 2024 (USD Million)
      • 9.2.7.4. Market size, by application, 2013 - 2024 (USD Million)
      • 9.2.7.5. Market size, by end-use, 2013 - 2024 (USD Million)
    • 9.2.8. Canada
      • 9.2.8.1. Market size, by product, 2013 - 2024 (USD Million)
        • 9.2.8.1.1. Market size, by glucose monitoring, 2013 - 2024 (USD Million)
        • 9.2.8.1.2. Market size, by cardiometabolic testing products, 2013 - 2024 (USD Million)
        • 9.2.8.1.3. Market size, by infectious disease testing products, 2013 - 2024 (USD Million)
        • 9.2.8.1.4. Market size, by coagulation testing products, 2013 - 2024 (USD Million)
        • 9.2.8.1.5. Market size, by pregnancy and fertility testing products, 2013 - 2024 (USD Million)
      • 9.2.8.2. Market size, by technology, 2013 - 2024 (USD Million)
      • 9.2.8.3. Market size, by prescription, 2013 - 2024 (USD Million)
      • 9.2.8.4. Market size, by application, 2013 - 2024 (USD Million)
      • 9.2.8.5. Market size, by end-use, 2013 - 2024 (USD Million)
  • 9.3. Europe
    • 9.3.1. Market size, by country, 2013 - 2024 (USD Million)
    • 9.3.2. Market size, by product, 2013 - 2024 (USD Million)
      • 9.3.2.1. Market size, by glucose monitoring, 2013 - 2024 (USD Million)
      • 9.3.2.2. Market size, by cardiometabolic testing products, 2013 - 2024 (USD Million)
      • 9.3.2.3. Market size, by infectious disease testing products, 2013 - 2024 (USD Million)
      • 9.3.2.4. Market size, by coagulation testing products, 2013 - 2024 (USD Million)
      • 9.3.2.5. Market size, by pregnancy and fertility testing products, 2013 - 2024 (USD Million)
    • 9.3.3. Market size, by technology, 2013 - 2024 (USD Million)
    • 9.3.4. Market size, by prescription, 2013 - 2024 (USD Million)
    • 9.3.5. Market size, by application, 2013 - 2024 (USD Million)
    • 9.3.6. Market size, by end-use, 2013 - 2024 (USD Million)
    • 9.3.7. Germany
      • 9.3.7.1. Market size, by product, 2013 - 2024 (USD Million)
        • 9.3.7.1.1. Market size, by glucose monitoring, 2013 - 2024 (USD Million)
        • 9.3.7.1.2. Market size, by cardiometabolic testing products, 2013 - 2024 (USD Million)
        • 9.3.7.1.3. Market size, by infectious disease testing products, 2013 - 2024 (USD Million)
        • 9.3.7.1.4. Market size, by coagulation testing products, 2013 - 2024 (USD Million)
        • 9.3.7.1.5. Market size, by pregnancy and fertility testing products, 2013 - 2024 (USD Million)
      • 9.3.7.2. Market size, by technology, 2013 - 2024 (USD Million)
      • 9.3.7.3. Market size, by prescription, 2013 - 2024 (USD Million)
      • 9.3.7.4. Market size, by application, 2013 - 2024 (USD Million)
      • 9.3.7.5. Market size, by end-use, 2013 - 2024 (USD Million)
    • 9.3.8. UK
      • 9.3.8.1. Market size, by product, 2013 - 2024 (USD Million)
        • 9.3.8.1.1. Market size, by glucose monitoring, 2013 - 2024 (USD Million)
        • 9.3.8.1.2. Market size, by cardiometabolic testing products, 2013 - 2024 (USD Million)
        • 9.3.8.1.3. Market size, by infectious disease testing products, 2013 - 2024 (USD Million)
        • 9.3.8.1.4. Market size, by coagulation testing products, 2013 - 2024 (USD Million)
        • 9.3.8.1.5. Market size, by pregnancy and fertility testing products, 2013 - 2024 (USD Million)
      • 9.3.8.2. Market size, by technology, 2013 - 2024 (USD Million)
      • 9.3.8.3. Market size, by prescription, 2013 - 2024 (USD Million)
      • 9.3.8.4. Market size, by application, 2013 - 2024 (USD Million)
      • 9.3.8.5. Market size, by end-use, 2013 - 2024 (USD Million)
    • 9.3.9. France
      • 9.3.9.1. Market size, by product, 2013 - 2024 (USD Million)
        • 9.3.9.1.1. Market size, by glucose monitoring, 2013 - 2024 (USD Million)
        • 9.3.9.1.2. Market size, by cardiometabolic testing products, 2013 - 2024 (USD Million)
        • 9.3.9.1.3. Market size, by infectious disease testing products, 2013 - 2024 (USD Million)
        • 9.3.9.1.4. Market size, by coagulation testing products, 2013 - 2024 (USD Million)
        • 9.3.9.1.5. Market size, by pregnancy and fertility testing products, 2013 - 2024 (USD Million)
      • 9.3.9.2. Market size, by technology, 2013 - 2024 (USD Million)
      • 9.3.9.3. Market size, by prescription, 2013 - 2024 (USD Million)
      • 9.3.9.4. Market size, by application, 2013 - 2024 (USD Million)
      • 9.3.9.5. Market size, by end-use, 2013 - 2024 (USD Million)
    • 9.3.10. Spain
      • 9.3.10.1. Market size, by product, 2013 - 2024 (USD Million)
        • 9.3.10.1.1. Market size, by glucose monitoring, 2013 - 2024 (USD Million)
        • 9.3.10.1.2. Market size, by cardiometabolic testing products, 2013 - 2024 (USD Million)
        • 9.3.10.1.3. Market size, by infectious disease testing products, 2013 - 2024 (USD Million)
        • 9.3.10.1.4. Market size, by coagulation testing products, 2013 - 2024 (USD Million)
        • 9.3.10.1.5. Market size, by pregnancy and fertility testing products, 2013 - 2024 (USD Million)
      • 9.3.10.2. Market size, by technology, 2013 - 2024 (USD Million)
      • 9.3.10.3. Market size, by prescription, 2013 - 2024 (USD Million)
      • 9.3.10.4. Market size, by application, 2013 - 2024 (USD Million)
      • 9.3.10.5. Market size, by end-use, 2013 - 2024 (USD Million)
    • 9.3.11. Italy
      • 9.3.11.1. Market size, by product, 2013 - 2024 (USD Million)
        • 9.3.11.1.1. Market size, by glucose monitoring, 2013 - 2024 (USD Million)
        • 9.3.11.1.2. Market size, by cardiometabolic testing products, 2013 - 2024 (USD Million)
        • 9.3.11.1.3. Market size, by infectious disease testing products, 2013 - 2024 (USD Million)
        • 9.3.11.1.4. Market size, by coagulation testing products, 2013 - 2024 (USD Million)
        • 9.3.11.1.5. Market size, by pregnancy and fertility testing products, 2013 - 2024 (USD Million)
      • 9.3.11.2. Market size, by technology, 2013 - 2024 (USD Million)
      • 9.3.11.3. Market size, by prescription, 2013 - 2024 (USD Million)
      • 9.3.11.4. Market size, by application, 2013 - 2024 (USD Million)
      • 9.3.11.5. Market size, by end-use, 2013 - 2024 (USD Million)
  • 9.4. Asia Pacific
    • 9.4.1. Market size, by country, 2013 - 2024 (USD Million)
    • 9.4.2. Market size, by product, 2013 - 2024 (USD Million)
      • 9.4.2.1. Market size, by glucose monitoring, 2013 - 2024 (USD Million)
      • 9.4.2.2. Market size, by cardiometabolic testing products, 2013 - 2024 (USD Million)
      • 9.4.2.3. Market size, by infectious disease testing products, 2013 - 2024 (USD Million)
      • 9.4.2.4. Market size, by coagulation testing products, 2013 - 2024 (USD Million)
      • 9.4.2.5. Market size, by pregnancy and fertility testing products, 2013 - 2024 (USD Million)
    • 9.4.3. Market size, by technology, 2013 - 2024 (USD Million)
    • 9.4.4. Market size, by prescription, 2013 - 2024 (USD Million)
    • 9.4.5. Market size, by application, 2013 - 2024 (USD Million)
    • 9.4.6. Market size, by end-use, 2013 - 2024 (USD Million)
    • 9.4.7. China
      • 9.4.7.1. Market size, by product, 2013 - 2024 (USD Million)
        • 9.4.7.1.1. Market size, by glucose monitoring, 2013 - 2024 (USD Million)
        • 9.4.7.1.2. Market size, by cardiometabolic testing products, 2013 - 2024 (USD Million)
        • 9.4.7.1.3. Market size, by infectious disease testing products, 2013 - 2024 (USD Million)
        • 9.4.7.1.4. Market size, by coagulation testing products, 2013 - 2024 (USD Million)
        • 9.4.7.1.5. Market size, by pregnancy and fertility testing products, 2013 - 2024 (USD Million)
      • 9.4.7.2. Market size, by technology, 2013 - 2024 (USD Million)
      • 9.4.7.3. Market size, by prescription, 2013 - 2024 (USD Million)
      • 9.4.7.4. Market size, by application, 2013 - 2024 (USD Million)
      • 9.4.7.5. Market size, by end-use, 2013 - 2024 (USD Million)
    • 9.4.8. India
      • 9.4.8.1. Market size, by product, 2013 - 2024 (USD Million)
        • 9.4.8.1.1. Market size, by glucose monitoring, 2013 - 2024 (USD Million)
        • 9.4.8.1.2. Market size, by cardiometabolic testing products, 2013 - 2024 (USD Million)
        • 9.4.8.1.3. Market size, by infectious disease testing products, 2013 - 2024 (USD Million)
        • 9.4.8.1.4. Market size, by coagulation testing products, 2013 - 2024 (USD Million)
        • 9.4.8.1.5. Market size, by pregnancy and fertility testing products, 2013 - 2024 (USD Million)
      • 9.4.8.2. Market size, by technology, 2013 - 2024 (USD Million)
      • 9.4.8.3. Market size, by prescription, 2013 - 2024 (USD Million)
      • 9.4.8.4. Market size, by application, 2013 - 2024 (USD Million)
      • 9.4.8.5. Market size, by end-use, 2013 - 2024 (USD Million)
    • 9.4.9. Japan
      • 9.4.9.1. Market size, by product, 2013 - 2024 (USD Million)
        • 9.4.9.1.1. Market size, by glucose monitoring, 2013 - 2024 (USD Million)
        • 9.4.9.1.2. Market size, by cardiometabolic testing products, 2013 - 2024 (USD Million)
        • 9.4.9.1.3. Market size, by infectious disease testing products, 2013 - 2024 (USD Million)
        • 9.4.9.1.4. Market size, by coagulation testing products, 2013 - 2024 (USD Million)
        • 9.4.9.1.5. Market size, by pregnancy and fertility testing products, 2013 - 2024 (USD Million)
      • 9.4.9.2. Market size, by technology, 2013 - 2024 (USD Million)
      • 9.4.9.3. Market size, by prescription, 2013 - 2024 (USD Million)
      • 9.4.9.4. Market size, by application, 2013 - 2024 (USD Million)
      • 9.4.9.5. Market size, by end-use, 2013 - 2024 (USD Million)
    • 9.4.10. Australia
      • 9.4.10.1. Market size, by product, 2013 - 2024 (USD Million)
        • 9.4.10.1.1. Market size, by glucose monitoring, 2013 - 2024 (USD Million)
        • 9.4.10.1.2. Market size, by cardiometabolic testing products, 2013 - 2024 (USD Million)
        • 9.4.10.1.3. Market size, by infectious disease testing products, 2013 - 2024 (USD Million)
        • 9.4.10.1.4. Market size, by coagulation testing products, 2013 - 2024 (USD Million)
        • 9.4.10.1.5. Market size, by pregnancy and fertility testing products, 2013 - 2024 (USD Million)
      • 9.4.10.2. Market size, by technology, 2013 - 2024 (USD Million)
      • 9.4.10.3. Market size, by prescription, 2013 - 2024 (USD Million)
      • 9.4.10.4. Market size, by application, 2013 - 2024 (USD Million)
      • 9.4.10.5. Market size, by end-use, 2013 - 2024 (USD Million)
  • 9.5. Latin America
    • 9.5.1. Market size, by country, 2013 - 2024 (USD Million)
    • 9.5.2. Market size, by product, 2013 - 2024 (USD Million)
      • 9.5.2.1. Market size, by glucose monitoring, 2013 - 2024 (USD Million)
      • 9.5.2.2. Market size, by cardiometabolic testing products, 2013 - 2024 (USD Million)
      • 9.5.2.3. Market size, by infectious disease testing products, 2013 - 2024 (USD Million)
      • 9.5.2.4. Market size, by coagulation testing products, 2013 - 2024 (USD Million)
      • 9.5.2.5. Market size, by pregnancy and fertility testing products, 2013 - 2024 (USD Million)
    • 9.5.3. Market size, by technology, 2013 - 2024 (USD Million)
    • 9.5.4. Market size, by prescription, 2013 - 2024 (USD Million)
    • 9.5.5. Market size, by application, 2013 - 2024 (USD Million)
    • 9.5.6. Market size, by end-use, 2013 - 2024 (USD Million)
    • 9.5.7. Brazil
      • 9.5.7.1. Market size, by product, 2013 - 2024 (USD Million)
        • 9.5.7.1.1. Market size, by glucose monitoring, 2013 - 2024 (USD Million)
        • 9.5.7.1.2. Market size, by cardiometabolic testing products, 2013 - 2024 (USD Million)
        • 9.5.7.1.3. Market size, by infectious disease testing products, 2013 - 2024 (USD Million)
        • 9.5.7.1.4. Market size, by coagulation testing products, 2013 - 2024 (USD Million)
        • 9.5.7.1.5. Market size, by pregnancy and fertility testing products, 2013 - 2024 (USD Million)
      • 9.5.7.2. Market size, by technology, 2013 - 2024 (USD Million)
      • 9.5.7.3. Market size, by prescription, 2013 - 2024 (USD Million)
      • 9.5.7.4. Market size, by application, 2013 - 2024 (USD Million)
      • 9.5.7.5. Market size, by end-use, 2013 - 2024 (USD Million)
    • 9.5.8. Mexico
      • 9.5.8.1. Market size, by product, 2013 - 2024 (USD Million)
        • 9.5.8.1.1. Market size, by glucose monitoring, 2013 - 2024 (USD Million)
        • 9.5.8.1.2. Market size, by cardiometabolic testing products, 2013 - 2024 (USD Million)
        • 9.5.8.1.3. Market size, by infectious disease testing products, 2013 - 2024 (USD Million)
        • 9.5.8.1.4. Market size, by coagulation testing products, 2013 - 2024 (USD Million)
        • 9.5.8.1.5. Market size, by pregnancy and fertility testing products, 2013 - 2024 (USD Million)
      • 9.5.8.2. Market size, by technology, 2013 - 2024 (USD Million)
      • 9.5.8.3. Market size, by prescription, 2013 - 2024 (USD Million)
      • 9.5.8.4. Market size, by application, 2013 - 2024 (USD Million)
      • 9.5.8.5. Market size, by end-use, 2013 - 2024 (USD Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Market size, by country, 2013 - 2024 (USD Million)
    • 9.6.2. Market size, by product, 2013 - 2024 (USD Million)
      • 9.6.2.1. Market size, by glucose monitoring, 2013 - 2024 (USD Million)
      • 9.6.2.2. Market size, by cardiometabolic testing products, 2013 - 2024 (USD Million)
      • 9.6.2.3. Market size, by infectious disease testing products, 2013 - 2024 (USD Million)
      • 9.6.2.4. Market size, by coagulation testing products, 2013 - 2024 (USD Million)
      • 9.6.2.5. Market size, by pregnancy and fertility testing products, 2013 - 2024 (USD Million)
    • 9.6.3. Market size, by technology, 2013 - 2024 (USD Million)
    • 9.6.4. Market size, by prescription, 2013 - 2024 (USD Million)
    • 9.6.5. Market size, by application, 2013 - 2024 (USD Million)
    • 9.6.6. Market size, by end-use, 2013 - 2024 (USD Million)
    • 9.6.7. South Africa
      • 9.6.7.1. Market size, by product, 2013 - 2024 (USD Million)
        • 9.6.7.1.1. Market size, by glucose monitoring, 2013 - 2024 (USD Million)
        • 9.6.7.1.2. Market size, by cardiometabolic testing products, 2013 - 2024 (USD Million)
        • 9.6.7.1.3. Market size, by infectious disease testing products, 2013 - 2024 (USD Million)
        • 9.6.7.1.4. Market size, by coagulation testing products, 2013 - 2024 (USD Million)
        • 9.6.7.1.5. Market size, by pregnancy and fertility testing products, 2013 - 2024 (USD Million)
      • 9.6.7.2. Market size, by technology, 2013 - 2024 (USD Million)
      • 9.6.7.3. Market size, by prescription, 2013 - 2024 (USD Million)
      • 9.6.7.4. Market size, by application, 2013 - 2024 (USD Million)
      • 9.6.7.5. Market size, by end-use, 2013 - 2024 (USD Million)
    • 9.6.8. Saudi Arabia
      • 9.6.8.1. Market size, by product, 2013 - 2024 (USD Million)
        • 9.6.8.1.1. Market size, by glucose monitoring, 2013 - 2024 (USD Million)
        • 9.6.8.1.2. Market size, by cardiometabolic testing products, 2013 - 2024 (USD Million)
        • 9.6.8.1.3. Market size, by infectious disease testing products, 2013 - 2024 (USD Million)
        • 9.6.8.1.4. Market size, by coagulation testing products, 2013 - 2024 (USD Million)
        • 9.6.8.1.5. Market size, by pregnancy and fertility testing products, 2013 - 2024 (USD Million)
      • 9.6.8.2. Market size, by technology, 2013 - 2024 (USD Million)
      • 9.6.8.3. Market size, by prescription, 2013 - 2024 (USD Million)
      • 9.6.8.4. Market size, by application, 2013 - 2024 (USD Million)
      • 9.6.8.5. Market size, by end-use, 2013 - 2024 (USD Million)

Chapter 10. Company Profiles

  • 10.1. Abaxis, Inc.
    • 10.1.1. Business overview
    • 10.1.2. Financial data
    • 10.1.3. Product landscape
    • 10.1.4. Strategic outlook
    • 10.1.5. SWOT analysis
  • 10.2. Abbott Laboratories
    • 10.2.1. Business overview
    • 10.2.2. Financial data
    • 10.2.3. Product landscape
    • 10.2.4. Strategic outlook
    • 10.2.5. SWOT analysis
  • 10.3. Accubiotech Co, Ltd.
    • 10.3.1. Business overview
    • 10.3.2. Financial data
    • 10.3.3. Product landscape
    • 10.3.4. Strategic outlook
    • 10.3.5. SWOT analysis
  • 10.4. ACON Laboratories, Inc.
    • 10.4.1. Business overview
    • 10.4.2. Financial data
    • 10.4.3. Product landscape
    • 10.4.4. Strategic outlook
    • 10.4.5. SWOT analysis
  • 10.5. Alere Inc.
    • 10.5.1. Business overview
    • 10.5.2. Financial data
    • 10.5.3. Product landscape
    • 10.5.4. Strategic outlook
    • 10.5.5. SWOT analysis
  • 10.6. Becton, Dickinson and Company
    • 10.6.1. Business overview
    • 10.6.2. Financial data
    • 10.6.3. Product landscape
    • 10.6.4. Strategic outlook
    • 10.6.5. SWOT analysis
  • 10.7. Biolytical Laboratories
    • 10.7.1. Business overview
    • 10.7.2. Financial data
    • 10.7.3. Product landscape
    • 10.7.4. Strategic outlook
    • 10.7.5. SWOT analysis
  • 10.8. bioMrieux SA
    • 10.8.1. Business overview
    • 10.8.2. Financial data
    • 10.8.3. Product landscape
    • 10.8.4. Strategic outlook
    • 10.8.5. SWOT analysis
  • 10.9. Bio-Rad Laboratories, Inc.
    • 10.9.1. Business overview
    • 10.9.2. Financial data
    • 10.9.3. Product landscape
    • 10.9.4. Strategic outlook
    • 10.9.5. SWOT analysis
  • 10.10. Danaher Corporation (HemoCue)
    • 10.10.1. Business overview
    • 10.10.2. Financial data
    • 10.10.3. Product landscape
    • 10.10.4. Strategic outlook
    • 10.10.5. SWOT analysis
  • 10.11. Dexcom, Inc.
    • 10.11.1. Business overview
    • 10.11.2. Financial data
    • 10.11.3. Product landscape
    • 10.11.4. Strategic outlook
    • 10.11.5. SWOT analysis
  • 10.12. Dragerwerk Ag & Co.
    • 10.12.1. Business overview
    • 10.12.2. Financial data
    • 10.12.3. Product landscape
    • 10.12.4. Strategic outlook
    • 10.12.5. SWOT analysis
  • 10.13. Johnson & Johnson
    • 10.13.1. Business overview
    • 10.13.2. Financial data
    • 10.13.3. Product landscape
    • 10.13.4. Strategic outlook
    • 10.13.5. SWOT analysis
  • 10.14. Medtronic
    • 10.14.1. Business overview
    • 10.14.2. Financial data
    • 10.14.3. Product landscape
    • 10.14.4. Strategic outlook
    • 10.14.5. SWOT analysis
  • 10.15. Meridian Bioscience, Inc.
    • 10.15.1. Business overview
    • 10.15.2. Financial data
    • 10.15.3. Product landscape
    • 10.15.4. Strategic outlook
    • 10.15.5. SWOT analysis
  • 10.16. Nova Biomedical
    • 10.16.1. Business overview
    • 10.16.2. Financial data
    • 10.16.3. Product landscape
    • 10.16.4. Strategic outlook
    • 10.16.5. SWOT analysis
  • 10.17. Orasure Technologies, Inc.
    • 10.17.1. Business overview
    • 10.17.2. Financial data
    • 10.17.3. Product landscape
    • 10.17.4. Strategic outlook
    • 10.17.5. SWOT analysis
  • 10.18. Roche Diagnostic Corporation
    • 10.18.1. Business overview
    • 10.18.2. Financial data
    • 10.18.3. Product landscape
    • 10.18.4. Strategic outlook
    • 10.18.5. SWOT analysis
  • 10.19. Siemens Healthineers
    • 10.19.1. Business overview
    • 10.19.2. Financial data
    • 10.19.3. Product landscape
    • 10.19.4. Strategic outlook
    • 10.19.5. SWOT analysis
  • 10.20. Sysmex Corporation
    • 10.20.1. Business overview
    • 10.20.2. Financial data
    • 10.20.3. Product landscape
    • 10.20.4. Strategic outlook
    • 10.20.5. SWOT analysis
  • 10.21. Trinity Biotech
    • 10.21.1. Business overview
    • 10.21.2. Financial data
    • 10.21.3. Product landscape
    • 10.21.4. Strategic outlook
    • 10.21.5. SWOT analysis

Data Tables

  • TABLE 1: Point of care testing industry 360 degree synopsis, 2013 - 2024
  • TABLE 2: Global point of care testing market, 2013 - 2017 (USD Million)
  • TABLE 3: Global point of care testing market, 2017 - 2024 (USD Million)
  • TABLE 4: Global point of care testing market, by product, 2013 - 2017 (USD Million)
  • TABLE 5: Global point of care testing market, by product, 2018 - 2024 (USD Million)
  • TABLE 6: Global point of care testing market, by technology, 2013 - 2017 (USD Million)
  • TABLE 7: Global point of care testing market, by technology, 2018 - 2024 (USD Million)
  • TABLE 8: Global point of care testing market, by prescription, 2013 - 2017 (USD Million)
  • TABLE 9: Global point of care testing market, by prescription, 2018 - 2024 (USD Million)
  • TABLE 10: Global point of care testing market, by application, 2013 - 2017 (USD Million)
  • TABLE 11: Global point of care testing market, by application, 2018 - 2024 (USD Million)
  • TABLE 12: Global point of care testing market, by end-use, 2013 - 2017 (USD Million)
  • TABLE 13: Global point of care testing market, by end-use, 2018 - 2024 (USD Million)
  • TABLE 14: Global point of care testing market, by region, 2013 - 2017 (USD Million)
  • TABLE 15: Global point of care testing market, by end-user, 2018 - 2024 (USD Million)
  • TABLE 16: Industry impact forces
  • TABLE 17: Global market share analysis, by setting and application
  • TABLE 18: F: Hoffmann-La Roche Ltd.'s global market share analysis, by setting and application
  • TABLE 19: Abbott's global market share analysis, by setting and application
  • TABLE 20: Johnson and Johnson's global market share analysis, by setting and application
  • TABLE 21: Siemens AG's global market share analysis, by setting and application
  • TABLE 22: Abaxis' global market share analysis, by setting and application
  • TABLE 23: Glucose monitoring market size, by region, 2013 - 2017 (USD Million)
  • TABLE 24: Glucose monitoring market size, by region, 2018 - 2024 (USD Million)
  • TABLE 25: Strips market size, by region, 2013 - 2017 (USD Million)
  • TABLE 26: Strips market size, by region, 2018 - 2024 (USD Million)
  • TABLE 27: Meters market size, by region, 2013 - 2017 (USD Million)
  • TABLE 28: Meters market size, by region, 2018 - 2024 (USD Million)
  • TABLE 29: Lancets market size, by region, 2013 - 2017 (USD Million)
  • TABLE 30: Lancets market size, by region, 2018 - 2024 (USD Million)
  • TABLE 31: Cardiometabolic testing products market size, by region, 2013 - 2017 (USD Million)
  • TABLE 32: Cardiometabolic testing products market size, by region, 2018 - 2024 (USD Million)
  • TABLE 33: Cardiac marker market size, by region, 2013 - 2017 (USD Million)
  • TABLE 34: Cardiac marker market size, by region, 2018 - 2024 (USD Million)
  • TABLE 35: Blood gas/electrolytes testing products market size, by region, 2013 - 2017 (USD Million)
  • TABLE 36: Blood gas/electrolytes testing products market size, by region, 2018 - 2024 (USD Million)
  • TABLE 37: HBA1C testing products market size, by region, 2013 - 2017 (USD Million)
  • TABLE 38: HBA1C testing products market size, by region, 2018 - 2024 (USD Million)
  • TABLE 39: Infectious disease testing products market size, by region, 2013 - 2017 (USD Million)
  • TABLE 40: Infectious disease testing products market size, by region, 2018 - 2024 (USD Million)
  • TABLE 41: Influenza testing products market size, by region, 2013 - 2017 (USD Million)
  • TABLE 42: Influenza testing products market size, by region, 2018 - 2024 (USD Million)
  • TABLE 43: HIV testing products market size, by region, 2013 - 2017 (USD Million)
  • TABLE 44: HIV testing products market size, by region, 2018 - 2024 (USD Million)
  • TABLE 45: Hepatitis C testing products market size, by region, 2013 - 2017 (USD Million)
  • TABLE 46: Hepatitis C testing products market size, by region, 2018 - 2024 (USD Million)
  • TABLE 47: Sexually transmitted disease (STD) testing products market size, by region, 2013 - 2017 (USD Million)
  • TABLE 48: Sexually transmitted disease (STD) testing products market size, by region, 2018 - 2024 (USD Million)
  • TABLE 49: Healthcare-associated infection (HAI) testing products market size, by region, 2013 - 2017 (USD Million)
  • TABLE 50: Healthcare-associated infection (HAI) testing products market size, by region, 2018 - 2024 (USD Million)
  • TABLE 51: Respiratory infection testing products market size, by region, 2013 - 2017 (USD Million)
  • TABLE 52: Respiratory infection testing products market size, by region, 2018 - 2024 (USD Million)
  • TABLE 53: Tropical disease testing products market size, by region, 2013 - 2017 (USD Million)
  • TABLE 54: Tropical disease testing products market size, by region, 2018 - 2024 (USD Million)
  • TABLE 55: Other infectious diseases testing products market size, by region, 2013 - 2017 (USD Million)
  • TABLE 56: Other infectious diseases testing products market size, by region, 2018 - 2024 (USD Million)
  • TABLE 57: Coagulation testing products market size, by region, 2013 - 2017 (USD Million)
  • TABLE 58: Coagulation testing products market size, by region, 2018 - 2024 (USD Million)
  • TABLE 59: PT/INR testing products market size, by region, 2013 - 2017 (USD Million)
  • TABLE 60: PT/INR testing products market size, by region, 2018 - 2024 (USD Million)
  • TABLE 61: Activated clotting time (ACT/APTT) testing products market size, by region, 2013 - 2017 (USD Million)
  • TABLE 62: Activated clotting time (ACT/APTT) testing products market size, by region, 2018 - 2024 (USD Million)
  • TABLE 63: Pregnancy and fertility testing products market size, by region, 2013 - 2017 (USD Million)
  • TABLE 64: Pregnancy and fertility testing products market size, by region, 2018 - 2024 (USD Million)
  • TABLE 65: Pregnancy testing products market size, by region, 2013 - 2017 (USD Million)
  • TABLE 66: Pregnancy testing products market size, by region, 2018 - 2024 (USD Million)
  • TABLE 67: Fertility testing products market size, by region, 2013 - 2017 (USD Million)
  • TABLE 68: Fertility testing products market size, by region, 2018 - 2024 (USD Million)
  • TABLE 69: Tumor/cancer marker testing products market size, by region, 2013 - 2017 (USD Million)
  • TABLE 70: Tumor/cancer marker testing products market size, by region, 2018 - 2024 (USD Million)
  • TABLE 71: Urinalysis testing products market size, by region, 2013 - 2017 (USD Million)
  • TABLE 72: Urinalysis testing products market size, by region, 2018 - 2024 (USD Million)
  • TABLE 73: Cholesterol testing products market size, by region, 2013 - 2017 (USD Million)
  • TABLE 74: Cholesterol testing products market size, by region, 2018 - 2024 (USD Million)
  • TABLE 75: Hematology testing products market size, by region, 2013 - 2017 (USD Million)
  • TABLE 76: Hematology testing products market size, by region, 2018 - 2024 (USD Million)
  • TABLE 77: Drug-of-Abuse testing products market size, by region, 2013 - 2017 (USD Million)
  • TABLE 78: Drug-of-Abuse testing products market size, by region, 2018 - 2024 (USD Million)
  • TABLE 79: Fecal occult testing products market size, by region, 2013 - 2017 (USD Million)
  • TABLE 80: Fecal occult testing products market size, by region, 2018 - 2024 (USD Million)
  • TABLE 81: Other products market size, by region, 2013 - 2017 (USD Million)
  • TABLE 82: Other products market size, by region, 2018 - 2024 (USD Million)
  • TABLE 83: Lateral flow assays market size, by region, 2013 - 2017 (USD Million)
  • TABLE 84: Lateral flow assays market size, by region, 2018 - 2024 (USD Million)
  • TABLE 85: Dipsticks market size, by region, 2013 - 2017 (USD Million)
  • TABLE 86: Dipsticks market size, by region, 2018 - 2024 (USD Million)
  • TABLE 87: Microfluidics market size, by region, 2013 - 2017 (USD Million)
  • TABLE 88: Microfluidics market size, by region, 2018 - 2024 (USD Million)
  • TABLE 89: Molecular diagnostics market size, by region, 2013 - 2017 (USD Million)
  • TABLE 90: Molecular diagnostics market size, by region, 2018 - 2024 (USD Million)
  • TABLE 91: Immunoassays market size, by region, 2013 - 2017 (USD Million)
  • TABLE 92: Immunoassays market size, by region, 2018 - 2024 (USD Million)
  • TABLE 93: Agglutination assays market size, by region, 2013 - 2017 (USD Million)
  • TABLE 94: Agglutination assays market size, by region, 2018 - 2024 (USD Million)
  • TABLE 95: Flow-through market size, by region, 2013 - 2017 (USD Million)
  • TABLE 96: Flow-through market size, by region, 2018 - 2024 (USD Million)
  • TABLE 97: Solid phase market size, by region, 2013 - 2017 (USD Million)
  • TABLE 98: Solid phase market size, by region, 2018 - 2024 (USD Million)
  • TABLE 99: Biosensors market size, by region, 2013 - 2017 (USD Million)
  • TABLE 100: Biosensors market size, by region, 2018 - 2024 (USD Million)
  • TABLE 101: OTC testing market size, by region, 2013 - 2017 (USD Million)
  • TABLE 102: OTC testing market size, by region, 2018 - 2024 (USD Million)
  • TABLE 103: Prescription-based testing market size, by region, 2013 - 2017 (USD Million)
  • TABLE 104: Prescription-based testing market size, by region, 2018 - 2024 (USD Million)
  • TABLE 105: Cardio metabolic testing market size, by region, 2013 - 2017 (USD Million)
  • TABLE 106: Cardio metabolic testing market size, by region, 2018 - 2024 (USD Million)
  • TABLE 107: Infectious disease testing market size, by region, 2013 - 2017 (USD Million)
  • TABLE 108: Infectious disease testing market size, by region, 2018 - 2024 (USD Million)
  • TABLE 109: Nephrology testing market size, by region, 2013 - 2017 (USD Million)
  • TABLE 110: Nephrology testing market size, by region, 2018 - 2024 (USD Million)
  • TABLE 111: Drug-of-abuse testing market size, by region, 2013 - 2017 (USD Million)
  • TABLE 112: Drug-of-abuse testing market size, by region, 2018 - 2024 (USD Million)
  • TABLE 113: Blood glucose testing market size, by region, 2013 - 2017 (USD Million)
  • TABLE 114: Blood glucose testing market size, by region, 2018 - 2024 (USD Million)
  • TABLE 115: Pregnancy testing market size, by region, 2013 - 2017 (USD Million)
  • TABLE 116: Pregnancy testing market size, by region, 2018 - 2024 (USD Million)
  • TABLE 117: Cancer biomarker testing market size, by region, 2013 - 2017 (USD Million)
  • TABLE 118: Cancer biomarker testing market size, by region, 2018 - 2024 (USD Million)
  • TABLE 119: Other applications market size, by region, 2013 - 2017 (USD Million)
  • TABLE 120: Other applications market size, by region, 2018 - 2024 (USD Million)
  • TABLE 121: Hospitals market size, by region, 2013 - 2017 (USD Million)
  • TABLE 122: Hospitals market size, by region, 2018 - 2024 (USD Million)
  • TABLE 123: Diagnostic centers market size, by region, 2013 - 2017 (USD Million)
  • TABLE 124: Diagnostic centers market size, by region, 2018 - 2024 (USD Million)
  • TABLE 125: Research laboratories market size, by region, 2013 - 2017 (USD Million)
  • TABLE 126: Research laboratories market size, by region, 2018 - 2024 (USD Million)
  • TABLE 127: Home-care settings market size, by region, 2013 - 2017 (USD Million)
  • TABLE 128: Home-care settings market size, by region, 2018 - 2024 (USD Million)
  • TABLE 129: Other end-uses market size, by region, 2013 - 2017 (USD Million)
  • TABLE 130: Other end-uses market size, by region, 2018 - 2024 (USD Million)
  • TABLE 131: North America point of care testing market size, by country, 2013 - 2017 (USD Million)
  • TABLE 132: North America point of care testing market size, by country, 2018 - 2024 (USD Million)
  • TABLE 133: North America point of care testing market size, by product, 2013 - 2017 (USD Million)
  • TABLE 134: North America point of care testing market size, by product, 2018 - 2024 (USD Million)
  • TABLE 135: North America point of care testing market size, by glucose monitoring, 2013 - 2017 (USD Million)
  • TABLE 136: North America point of care testing market size, by glucose monitoring, 2018 - 2024 (USD Million)
  • TABLE 137: North America point of care testing market size, by cardiometabolic testing products, 2013 - 2017 (USD Million)
  • TABLE 138: North America point of care testing market size, by cardiometabolic testing products, 2018 - 2024 (USD Million)
  • TABLE 139: North America point of care testing market size, by infectious disease testing products, 2013 - 2017 (USD Million)
  • TABLE 140: North America point of care testing market size, by infectious disease testing products, 2018 - 2024 (USD Million)
  • TABLE 141: North America point of care testing market size, by coagulation testing products, 2013 - 2017 (USD Million)
  • TABLE 142: North America point of care testing market size, by coagulation testing products, 2018 - 2024 (USD Million)
  • TABLE 143: North America point of care testing market size, by pregnancy and fertility testing products, 2013 - 2017 (USD Million)
  • TABLE 144: North America point of care testing market size, by pregnancy and fertility testing products, 2018 - 2024 (USD Million)
  • TABLE 145: North America point of care testing market size, by technology, 2013 - 2017 (USD Million)
  • TABLE 146: North America point of care testing market size, by technology, 2018 - 2024 (USD Million)
  • TABLE 147: North America point of care testing market size, by prescription, 2013 - 2017 (USD Million)
  • TABLE 148: North America point of care testing market size, by prescription, 2018 - 2024 (USD Million)
  • TABLE 149: North America point of care testing market size, by application, 2013 - 2017 (USD Million)
  • TABLE 150: North America point of care testing market size, by application, 2018 - 2024 (USD Million)
  • TABLE 151: North America point of care testing market size, by end-use, 2013 - 2017 (USD Million)
  • TABLE 152: North America point of care testing market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 153: U.S: point of care testing market size, by product, 2013 - 2017 (USD Million)
  • TABLE 154: U.S: point of care testing market size, by product, 2018 - 2024 (USD Million)
  • TABLE 155: U.S: point of care testing market size, by glucose monitoring, 2013 - 2017 (USD Million)
  • TABLE 156: U.S: point of care testing market size, by glucose monitoring, 2018 - 2024 (USD Million)
  • TABLE 157: U.S: point of care testing market size, by cardiometabolic testing products, 2013 - 2017 (USD Million)
  • TABLE 158: U.S: point of care testing market size, by cardiometabolic testing products, 2018 - 2024 (USD Million)
  • TABLE 159: U.S: point of care testing market size, by infectious disease testing products, 2013 - 2017 (USD Million)
  • TABLE 160: U.S: point of care testing market size, by infectious disease testing products, 2018 - 2024 (USD Million)
  • TABLE 161: U.S: point of care testing market size, by coagulation testing products, 2013 - 2017 (USD Million)
  • TABLE 162: U.S: point of care testing market size, by coagulation testing products, 2018 - 2024 (USD Million)
  • TABLE 163: U.S: point of care testing market size, by pregnancy and fertility testing products, 2013 - 2017 (USD Million)
  • TABLE 164: U.S: point of care testing market size, by pregnancy and fertility testing products, 2018 - 2024 (USD Million)
  • TABLE 165: U.S: point of care testing market size, by technology, 2013 - 2017 (USD Million)
  • TABLE 166: U.S: point of care testing market size, by technology, 2018 - 2024 (USD Million)
  • TABLE 167: U.S: point of care testing market size, by prescription, 2013 - 2017 (USD Million)
  • TABLE 168: U.S: point of care testing market size, by prescription, 2018 - 2024 (USD Million)
  • TABLE 169: U.S: point of care testing market size, by application, 2013 - 2017 (USD Million)
  • TABLE 170: U.S: point of care testing market size, by application, 2018 - 2024 (USD Million)
  • TABLE 171: U.S: point of care testing market size, by end-use, 2013 - 2017 (USD Million)
  • TABLE 172: U.S: point of care testing market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 173: Canada point of care testing market size, by product, 2013 - 2017 (USD Million)
  • TABLE 174: Canada point of care testing market size, by product, 2018 - 2024 (USD Million)
  • TABLE 175: Canada point of care testing market size, by glucose monitoring, 2013 - 2017 (USD Million)
  • TABLE 176: Canada point of care testing market size, by glucose monitoring, 2018 - 2024 (USD Million)
  • TABLE 177: Canada point of care testing market size, by cardiometabolic testing products, 2013 - 2017 (USD Million)
  • TABLE 178: Canada point of care testing market size, by cardiometabolic testing products, 2018 - 2024 (USD Million)
  • TABLE 179: Canada point of care testing market size, by infectious disease testing products, 2013 - 2017 (USD Million)
  • TABLE 180: Canada point of care testing market size, by infectious disease testing products, 2018 - 2024 (USD Million)
  • TABLE 181: Canada point of care testing market size, by coagulation testing products, 2013 - 2017 (USD Million)
  • TABLE 182: Canada point of care testing market size, by coagulation testing products, 2018 - 2024 (USD Million)
  • TABLE 183: Canada point of care testing market size, by pregnancy and fertility testing products, 2013 - 2017 (USD Million)
  • TABLE 184: Canada point of care testing market size, by pregnancy and fertility testing products, 2018 - 2024 (USD Million)
  • TABLE 185: Canada point of care testing market size, by technology, 2013 - 2017 (USD Million)
  • TABLE 186: Canada point of care testing market size, by technology, 2018 - 2024 (USD Million)
  • TABLE 187: Canada point of care testing market size, by prescription, 2013 - 2017 (USD Million)
  • TABLE 188: Canada point of care testing market size, by prescription, 2018 - 2024 (USD Million)
  • TABLE 189: Canada point of care testing market size, by application, 2013 - 2017 (USD Million)
  • TABLE 190: Canada point of care testing market size, by application, 2018 - 2024 (USD Million)
  • TABLE 191: Canada point of care testing market size, by end-use, 2013 - 2017 (USD Million)
  • TABLE 192: Canada point of care testing market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 193: Europe point of care testing market size, by country, 2013 - 2017 (USD Million)
  • TABLE 194: Europe point of care testing market size, by country, 2018 - 2024 (USD Million)
  • TABLE 195: Europe point of care testing market size, by product, 2013 - 2017 (USD Million)
  • TABLE 196: Europe point of care testing market size, by product, 2018 - 2024 (USD Million)
  • TABLE 197: Europe point of care testing market size, by glucose monitoring, 2013 - 2017 (USD Million)
  • TABLE 198: Europe point of care testing market size, by glucose monitoring, 2018 - 2024 (USD Million)
  • TABLE 199: Europe point of care testing market size, by cardiometabolic testing products, 2013 - 2017 (USD Million)
  • TABLE 200: Europe point of care testing market size, by cardiometabolic testing products, 2018 - 2024 (USD Million)
  • TABLE 201: Europe point of care testing market size, by infectious disease testing products, 2013 - 2017 (USD Million)
  • TABLE 202: Europe point of care testing market size, by infectious disease testing products, 2018 - 2024 (USD Million)
  • TABLE 203: Europe point of care testing market size, by coagulation testing products, 2013 - 2017 (USD Million)
  • TABLE 204: Europe point of care testing market size, by coagulation testing products, 2018 - 2024 (USD Million)
  • TABLE 205: Europe point of care testing market size, by pregnancy and fertility testing products, 2013 - 2017 (USD Million)
  • TABLE 206: Europe point of care testing market size, by pregnancy and fertility testing products, 2018 - 2024 (USD Million)
  • TABLE 207: Europe point of care testing market size, by technology, 2013 - 2017 (USD Million)
  • TABLE 208: Europe point of care testing market size, by technology, 2018 - 2024 (USD Million)
  • TABLE 209: Europe point of care testing market size, by prescription, 2013 - 2017 (USD Million)
  • TABLE 210: Europe point of care testing market size, by prescription, 2018 - 2024 (USD Million)
  • TABLE 211: Europe point of care testing market size, by application, 2013 - 2017 (USD Million)
  • TABLE 212: Europe point of care testing market size, by application, 2018 - 2024 (USD Million)
  • TABLE 213: Europe point of care testing market size, by end-use, 2013 - 2017 (USD Million)
  • TABLE 214: Europe point of care testing market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 215: Germany point of care testing market size, by product, 2013 - 2017 (USD Million)
  • TABLE 216: Germany point of care testing market size, by product, 2018 - 2024 (USD Million)
  • TABLE 217: Germany point of care testing market size, by glucose monitoring, 2013 - 2017 (USD Million)
  • TABLE 218: Germany point of care testing market size, by glucose monitoring, 2018 - 2024 (USD Million)
  • TABLE 219: Germany point of care testing market size, by cardiometabolic testing products, 2013 - 2017 (USD Million)
  • TABLE 220: Germany point of care testing market size, by cardiometabolic testing products, 2018 - 2024 (USD Million)
  • TABLE 221: Germany point of care testing market size, by infectious disease testing products, 2013 - 2017 (USD Million)
  • TABLE 222: Germany point of care testing market size, by infectious disease testing products, 2018 - 2024 (USD Million)
  • TABLE 223: Germany point of care testing market size, by coagulation testing products, 2013 - 2017 (USD Million)
  • TABLE 224: Germany point of care testing market size, by coagulation testing products, 2018 - 2024 (USD Million)
  • TABLE 225: Germany point of care testing market size, by pregnancy and fertility testing products, 2013 - 2017 (USD Million)
  • TABLE 226: Germany point of care testing market size, by pregnancy and fertility testing products, 2018 - 2024 (USD Million)
  • TABLE 227: Germany point of care testing market size, by technology, 2013 - 2017 (USD Million)
  • TABLE 228: Germany point of care testing market size, by technology, 2018 - 2024 (USD Million)
  • TABLE 229: Germany point of care testing market size, by prescription, 2013 - 2017 (USD Million)
  • TABLE 230: Germany point of care testing market size, by prescription, 2018 - 2024 (USD Million)
  • TABLE 231: Germany point of care testing market size, by application, 2013 - 2017 (USD Million)
  • TABLE 232: Germany point of care testing market size, by application, 2018 - 2024 (USD Million)
  • TABLE 233: Germany point of care testing market size, by end-use, 2013 - 2017 (USD Million)
  • TABLE 234: Germany point of care testing market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 235: UK point of care testing market size, by product, 2013 - 2017 (USD Million)
  • TABLE 236: UK point of care testing market size, by product, 2018 - 2024 (USD Million)
  • TABLE 237: UK point of care testing market size, by glucose monitoring, 2013 - 2017 (USD Million)
  • TABLE 238: UK point of care testing market size, by glucose monitoring, 2018 - 2024 (USD Million)
  • TABLE 239: UK point of care testing market size, by cardiometabolic testing products, 2013 - 2017 (USD Million)
  • TABLE 240: UK point of care testing market size, by cardiometabolic testing products, 2018 - 2024 (USD Million)
  • TABLE 241: UK point of care testing market size, by infectious disease testing products, 2013 - 2017 (USD Million)
  • TABLE 242: UK point of care testing market size, by infectious disease testing products, 2018 - 2024 (USD Million)
  • TABLE 243: UK point of care testing market size, by coagulation testing products, 2013 - 2017 (USD Million)
  • TABLE 244: UK point of care testing market size, by coagulation testing products, 2018 - 2024 (USD Million)
  • TABLE 245: UK point of care testing market size, by pregnancy and fertility testing products, 2013 - 2017 (USD Million)
  • TABLE 246: UK point of care testing market size, by pregnancy and fertility testing products, 2018 - 2024 (USD Million)
  • TABLE 247: UK point of care testing market size, by technology, 2013 - 2017 (USD Million)
  • TABLE 248: UK point of care testing market size, by technology, 2018 - 2024 (USD Million)
  • TABLE 249: UK point of care testing market size, by prescription, 2013 - 2017 (USD Million)
  • TABLE 250: UK point of care testing market size, by prescription, 2018 - 2024 (USD Million)
  • TABLE 251: UK point of care testing market size, by application, 2013 - 2017 (USD Million)
  • TABLE 252: UK point of care testing market size, by application, 2018 - 2024 (USD Million)
  • TABLE 253: UK point of care testing market size, by end-use, 2013 - 2017 (USD Million)
  • TABLE 254: UK point of care testing market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 255: France point of care testing market size, by product, 2013 - 2017 (USD Million)
  • TABLE 256: France point of care testing market size, by product, 2018 - 2024 (USD Million)
  • TABLE 257: France point of care testing market size, by glucose monitoring, 2013 - 2017 (USD Million)
  • TABLE 258: France point of care testing market size, by glucose monitoring, 2018 - 2024 (USD Million)
  • TABLE 259: France point of care testing market size, by cardiometabolic testing products, 2013 - 2017 (USD Million)
  • TABLE 260: France point of care testing market size, by cardiometabolic testing products, 2018 - 2024 (USD Million)
  • TABLE 261: France point of care testing market size, by infectious disease testing products, 2013 - 2017 (USD Million)
  • TABLE 262: France point of care testing market size, by infectious disease testing products, 2018 - 2024 (USD Million)
  • TABLE 263: France point of care testing market size, by coagulation testing products, 2013 - 2017 (USD Million)
  • TABLE 264: France point of care testing market size, by coagulation testing products, 2018 - 2024 (USD Million)
  • TABLE 265: France point of care testing market size, by pregnancy and fertility testing products, 2013 - 2017 (USD Million)
  • TABLE 266: France point of care testing market size, by pregnancy and fertility testing products, 2018 - 2024 (USD Million)
  • TABLE 267: France point of care testing market size, by technology, 2013 - 2017 (USD Million)
  • TABLE 268: France point of care testing market size, by technology, 2018 - 2024 (USD Million)
  • TABLE 269: France point of care testing market size, by prescription, 2013 - 2017 (USD Million)
  • TABLE 270: France point of care testing market size, by prescription, 2018 - 2024 (USD Million)
  • TABLE 271: France point of care testing market size, by application, 2013 - 2017 (USD Million)
  • TABLE 272: France point of care testing market size, by application, 2018 - 2024 (USD Million)
  • TABLE 273: France point of care testing market size, by end-use, 2013 - 2017 (USD Million)
  • TABLE 274: France point of care testing market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 275: Spain point of care testing market size, by product, 2013 - 2017 (USD Million)
  • TABLE 276: Spain point of care testing market size, by product, 2018 - 2024 (USD Million)
  • TABLE 277: Spain point of care testing market size, by glucose monitoring, 2013 - 2017 (USD Million)
  • TABLE 278: Spain point of care testing market size, by glucose monitoring, 2018 - 2024 (USD Million)
  • TABLE 279: Spain point of care testing market size, by cardiometabolic testing products, 2013 - 2017 (USD Million)
  • TABLE 280: Spain point of care testing market size, by cardiometabolic testing products, 2018 - 2024 (USD Million)
  • TABLE 281: Spain point of care testing market size, by infectious disease testing products, 2013 - 2017 (USD Million)
  • TABLE 282: Spain point of care testing market size, by infectious disease testing products, 2018 - 2024 (USD Million)
  • TABLE 283: Spain point of care testing market size, by coagulation testing products, 2013 - 2017 (USD Million)
  • TABLE 284: Spain point of care testing market size, by coagulation testing products, 2018 - 2024 (USD Million)
  • TABLE 285: Spain point of care testing market size, by pregnancy and fertility testing products, 2013 - 2017 (USD Million)
  • TABLE 286: Spain point of care testing market size, by pregnancy and fertility testing products, 2018 - 2024 (USD Million)
  • TABLE 287: Spain point of care testing market size, by technology, 2013 - 2017 (USD Million)
  • TABLE 288: Spain point of care testing market size, by technology, 2018 - 2024 (USD Million)
  • TABLE 289: Spain point of care testing market size, by prescription, 2013 - 2017 (USD Million)
  • TABLE 290: Spain point of care testing market size, by prescription, 2018 - 2024 (USD Million)
  • TABLE 291: Spain point of care testing market size, by application, 2013 - 2017 (USD Million)
  • TABLE 292: Spain point of care testing market size, by application, 2018 - 2024 (USD Million)
  • TABLE 293: Spain point of care testing market size, by end-use, 2013 - 2017 (USD Million)
  • TABLE 294: Spain point of care testing market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 295: Italy point of care testing market size, by product, 2013 - 2017 (USD Million)
  • TABLE 296: Italy point of care testing market size, by product, 2018 - 2024 (USD Million)
  • TABLE 297: Italy point of care testing market size, by glucose monitoring, 2013 - 2017 (USD Million)
  • TABLE 298: Italy point of care testing market size, by glucose monitoring, 2018 - 2024 (USD Million)
  • TABLE 299: Italy point of care testing market size, by cardiometabolic testing products, 2013 - 2017 (USD Million)
  • TABLE 300: Italy point of care testing market size, by cardiometabolic testing products, 2018 - 2024 (USD Million)
  • TABLE 301: Italy point of care testing market size, by infectious disease testing products, 2013 - 2017 (USD Million)
  • TABLE 302: Italy point of care testing market size, by infectious disease testing products, 2018 - 2024 (USD Million)
  • TABLE 303: Italy point of care testing market size, by coagulation testing products, 2013 - 2017 (USD Million)
  • TABLE 304: Italy point of care testing market size, by coagulation testing products, 2018 - 2024 (USD Million)
  • TABLE 305: Italy point of care testing market size, by pregnancy and fertility testing products, 2013 - 2017 (USD Million)
  • TABLE 306: Italy point of care testing market size, by pregnancy and fertility testing products, 2018 - 2024 (USD Million)
  • TABLE 307: Italy point of care testing market size, by technology, 2013 - 2017 (USD Million)
  • TABLE 308: Italy point of care testing market size, by technology, 2018 - 2024 (USD Million)
  • TABLE 309: Italy point of care testing market size, by prescription, 2013 - 2017 (USD Million)
  • TABLE 310: Italy point of care testing market size, by prescription, 2018 - 2024 (USD Million)
  • TABLE 311: Italy point of care testing market size, by application, 2013 - 2017 (USD Million)
  • TABLE 312: Italy point of care testing market size, by application, 2018 - 2024 (USD Million)
  • TABLE 313: Italy point of care testing market size, by end-use, 2013 - 2017 (USD Million)
  • TABLE 314: Italy point of care testing market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 315: Asia Pacific point of care testing market size, by country, 2013 - 2017 (USD Million)
  • TABLE 316: Asia Pacific point of care testing market size, by country, 2018 - 2024 (USD Million)
  • TABLE 317: Asia Pacific point of care testing market size, by product, 2013 - 2017 (USD Million)
  • TABLE 318: Asia Pacific point of care testing market size, by product, 2018 - 2024 (USD Million)
  • TABLE 319: Asia Pacific point of care testing market size, by glucose monitoring, 2013 - 2017 (USD Million)
  • TABLE 320: Asia Pacific point of care testing market size, by glucose monitoring, 2018 - 2024 (USD Million)
  • TABLE 321: Asia Pacific point of care testing market size, by cardiometabolic testing products, 2013 - 2017 (USD Million)
  • TABLE 322: Asia Pacific point of care testing market size, by cardiometabolic testing products, 2018 - 2024 (USD Million)
  • TABLE 323: Asia Pacific point of care testing market size, by infectious disease testing products, 2013 - 2017 (USD Million)
  • TABLE 324: Asia Pacific point of care testing market size, by infectious disease testing products, 2018 - 2024 (USD Million)
  • TABLE 325: Asia Pacific point of care testing market size, by coagulation testing products, 2013 - 2017 (USD Million)
  • TABLE 326: Asia Pacific point of care testing market size, by coagulation testing products, 2018 - 2024 (USD Million)
  • TABLE 327: Asia Pacific point of care testing market size, by pregnancy and fertility testing products, 2013 - 2017 (USD Million)
  • TABLE 328: Asia Pacific point of care testing market size, by pregnancy and fertility testing products, 2018 - 2024 (USD Million)
  • TABLE 329: Asia Pacific point of care testing market size, by technology, 2013 - 2017 (USD Million)
  • TABLE 330: Asia Pacific point of care testing market size, by technology, 2018 - 2024 (USD Million)
  • TABLE 331: Asia Pacific point of care testing market size, by prescription, 2013 - 2017 (USD Million)
  • TABLE 332: Asia Pacific point of care testing market size, by prescription, 2018 - 2024 (USD Million)
  • TABLE 333: Asia Pacific point of care testing market size, by application, 2013 - 2017 (USD Million)
  • TABLE 334: Asia Pacific point of care testing market size, by application, 2018 - 2024 (USD Million)
  • TABLE 335: Asia Pacific point of care testing market size, by end-use, 2013 - 2017 (USD Million)
  • TABLE 336: Asia Pacific point of care testing market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 337: China point of care testing market size, by product, 2013 - 2017 (USD Million)
  • TABLE 338: China point of care testing market size, by product, 2018 - 2024 (USD Million)
  • TABLE 339: China point of care testing market size, by glucose monitoring, 2013 - 2017 (USD Million)
  • TABLE 340: China point of care testing market size, by glucose monitoring, 2018 - 2024 (USD Million)
  • TABLE 341: China point of care testing market size, by cardiometabolic testing products, 2013 - 2017 (USD Million)
  • TABLE 342: China point of care testing market size, by cardiometabolic testing products, 2018 - 2024 (USD Million)
  • TABLE 343: China point of care testing market size, by infectious disease testing products, 2013 - 2017 (USD Million)
  • TABLE 344: China point of care testing market size, by infectious disease testing products, 2018 - 2024 (USD Million)
  • TABLE 345: China point of care testing market size, by coagulation testing products, 2013 - 2017 (USD Million)
  • TABLE 346: China point of care testing market size, by coagulation testing products, 2018 - 2024 (USD Million)
  • TABLE 347: China point of care testing market size, by pregnancy and fertility testing products, 2013 - 2017 (USD Million)
  • TABLE 348: China point of care testing market size, by pregnancy and fertility testing products, 2018 - 2024 (USD Million)
  • TABLE 349: China point of care testing market size, by technology, 2013 - 2017 (USD Million)
  • TABLE 350: China point of care testing market size, by technology, 2018 - 2024 (USD Million)
  • TABLE 351: China point of care testing market size, by prescription, 2013 - 2017 (USD Million)
  • TABLE 352: China point of care testing market size, by prescription, 2018 - 2024 (USD Million)
  • TABLE 353: China point of care testing market size, by application, 2013 - 2017 (USD Million)
  • TABLE 354: China point of care testing market size, by application, 2018 - 2024 (USD Million)
  • TABLE 355: China point of care testing market size, by end-use, 2013 - 2017 (USD Million)
  • TABLE 356: China point of care testing market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 357: India point of care testing market size, by product, 2013 - 2017 (USD Million)
  • TABLE 358: India point of care testing market size, by product, 2018 - 2024 (USD Million)
  • TABLE 359: India point of care testing market size, by glucose monitoring, 2013 - 2017 (USD Million)
  • TABLE 360: India point of care testing market size, by glucose monitoring, 2018 - 2024 (USD Million)
  • TABLE 361: India point of care testing market size, by cardiometabolic testing products, 2013 - 2017 (USD Million)
  • TABLE 362: India point of care testing market size, by cardiometabolic testing products, 2018 - 2024 (USD Million)
  • TABLE 363: India point of care testing market size, by infectious disease testing products, 2013 - 2017 (USD Million)
  • TABLE 364: India point of care testing market size, by infectious disease testing products, 2018 - 2024 (USD Million)
  • TABLE 365: India point of care testing market size, by coagulation testing products, 2013 - 2017 (USD Million)
  • TABLE 366: India point of care testing market size, by coagulation testing products, 2018 - 2024 (USD Million)
  • TABLE 367: India point of care testing market size, by pregnancy and fertility testing products, 2013 - 2017 (USD Million)
  • TABLE 368: India point of care testing market size, by pregnancy and fertility testing products, 2018 - 2024 (USD Million)
  • TABLE 369: India point of care testing market size, by technology, 2013 - 2017 (USD Million)
  • TABLE 370: India point of care testing market size, by technology, 2018 - 2024 (USD Million)
  • TABLE 371: India point of care testing market size, by prescription, 2013 - 2017 (USD Million)
  • TABLE 372: India point of care testing market size, by prescription, 2018 - 2024 (USD Million)
  • TABLE 373: India point of care testing market size, by application, 2013 - 2017 (USD Million)
  • TABLE 374: India point of care testing market size, by application, 2018 - 2024 (USD Million)
  • TABLE 375: India point of care testing market size, by end-use, 2013 - 2017 (USD Million)
  • TABLE 376: India point of care testing market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 377: Japan point of care testing market size, by product, 2013 - 2017 (USD Million)
  • TABLE 378: Japan point of care testing market size, by product, 2018 - 2024 (USD Million)
  • TABLE 379: Japan point of care testing market size, by glucose monitoring, 2013 - 2017 (USD Million)
  • TABLE 380: Japan point of care testing market size, by glucose monitoring, 2018 - 2024 (USD Million)
  • TABLE 381: Japan point of care testing market size, by cardiometabolic testing products, 2013 - 2017 (USD Million)
  • TABLE 382: Japan point of care testing market size, by cardiometabolic testing products, 2018 - 2024 (USD Million)
  • TABLE 383: Japan point of care testing market size, by infectious disease testing products, 2013 - 2017 (USD Million)
  • TABLE 384: Japan point of care testing market size, by infectious disease testing products, 2018 - 2024 (USD Million)
  • TABLE 385: Japan point of care testing market size, by coagulation testing products, 2013 - 2017 (USD Million)
  • TABLE 386: Japan point of care testing market size, by coagulation testing products, 2018 - 2024 (USD Million)
  • TABLE 387: Japan point of care testing market size, by pregnancy and fertility testing products, 2013 - 2017 (USD Million)
  • TABLE 388: Japan point of care testing market size, by pregnancy and fertility testing products, 2018 - 2024 (USD Million)
  • TABLE 389: Japan point of care testing market size, by technology, 2013 - 2017 (USD Million)
  • TABLE 390: Japan point of care testing market size, by technology, 2018 - 2024 (USD Million)
  • TABLE 391: Japan point of care testing market size, by prescription, 2013 - 2017 (USD Million)
  • TABLE 392: Japan point of care testing market size, by prescription, 2018 - 2024 (USD Million)
  • TABLE 393: Japan point of care testing market size, by application, 2013 - 2017 (USD Million)
  • TABLE 394: Japan point of care testing market size, by application, 2018 - 2024 (USD Million)
  • TABLE 395: Japan point of care testing market size, by end-use, 2013 - 2017 (USD Million)
  • TABLE 396: Japan point of care testing market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 397: Australia point of care testing market size, by product, 2013 - 2017 (USD Million)
  • TABLE 398: Australia point of care testing market size, by product, 2018 - 2024 (USD Million)
  • TABLE 399: Australia point of care testing market size, by glucose monitoring, 2013 - 2017 (USD Million)
  • TABLE 400: Australia point of care testing market size, by glucose monitoring, 2018 - 2024 (USD Million)
  • TABLE 401: Australia point of care testing market size, by cardiometabolic testing products, 2013 - 2017 (USD Million)
  • TABLE 402: Australia point of care testing market size, by cardiometabolic testing products, 2018 - 2024 (USD Million)
  • TABLE 403: Australia point of care testing market size, by infectious disease testing products, 2013 - 2017 (USD Million)
  • TABLE 404: Australia point of care testing market size, by infectious disease testing products, 2018 - 2024 (USD Million)
  • TABLE 405: Australia point of care testing market size, by coagulation testing products, 2013 - 2017 (USD Million)
  • TABLE 406: Australia point of care testing market size, by coagulation testing products, 2018 - 2024 (USD Million)
  • TABLE 407: Australia point of care testing market size, by pregnancy and fertility testing products, 2013 - 2017 (USD Million)
  • TABLE 408: Australia point of care testing market size, by pregnancy and fertility testing products, 2018 - 2024 (USD Million)
  • TABLE 409: Australia point of care testing market size, by technology, 2013 - 2017 (USD Million)
  • TABLE 410: Australia point of care testing market size, by technology, 2018 - 2024 (USD Million)
  • TABLE 411: Australia point of care testing market size, by prescription, 2013 - 2017 (USD Million)
  • TABLE 412: Australia point of care testing market size, by prescription, 2018 - 2024 (USD Million)
  • TABLE 413: Australia point of care testing market size, by application, 2013 - 2017 (USD Million)
  • TABLE 414: Australia point of care testing market size, by application, 2018 - 2024 (USD Million)
  • TABLE 415: Australia point of care testing market size, by end-use, 2013 - 2017 (USD Million)
  • TABLE 416: Australia point of care testing market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 417: Latin America point of care testing market size, by country, 2013 - 2017 (USD Million)
  • TABLE 418: Latin America point of care testing market size, by country, 2018 - 2024 (USD Million)
  • TABLE 419: Latin America point of care testing market size, by product, 2013 - 2017 (USD Million)
  • TABLE 420: Latin America point of care testing market size, by product, 2018 - 2024 (USD Million)
  • TABLE 421: Latin America point of care testing market size, by glucose monitoring, 2013 - 2017 (USD Million)
  • TABLE 422: Latin America point of care testing market size, by glucose monitoring, 2018 - 2024 (USD Million)
  • TABLE 423: Latin America point of care testing market size, by cardiometabolic testing products, 2013 - 2017 (USD Million)
  • TABLE 424: Latin America point of care testing market size, by cardiometabolic testing products, 2018 - 2024 (USD Million)
  • TABLE 425: Latin America point of care testing market size, by infectious disease testing products, 2013 - 2017 (USD Million)
  • TABLE 426: Latin America point of care testing market size, by infectious disease testing products, 2018 - 2024 (USD Million)
  • TABLE 427: Latin America point of care testing market size, by coagulation testing products, 2013 - 2017 (USD Million)
  • TABLE 428: Latin America point of care testing market size, by coagulation testing products, 2018 - 2024 (USD Million)
  • TABLE 429: Latin America point of care testing market size, by pregnancy and fertility testing products, 2013 - 2017 (USD Million)
  • TABLE 430: Latin America point of care testing market size, by pregnancy and fertility testing products, 2018 - 2024 (USD Million)
  • TABLE 431: Latin America point of care testing market size, by technology, 2013 - 2017 (USD Million)
  • TABLE 432: Latin America point of care testing market size, by technology, 2018 - 2024 (USD Million)
  • TABLE 433: Latin America point of care testing market size, by prescription, 2013 - 2017 (USD Million)
  • TABLE 434: Latin America point of care testing market size, by prescription, 2018 - 2024 (USD Million)
  • TABLE 435: Latin America point of care testing market size, by application, 2013 - 2017 (USD Million)
  • TABLE 436: Latin America point of care testing market size, by application, 2018 - 2024 (USD Million)
  • TABLE 437: Latin America point of care testing market size, by end-use, 2013 - 2017 (USD Million)
  • TABLE 438: Latin America point of care testing market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 439: Brazil point of care testing market size, by product, 2013 - 2017 (USD Million)
  • TABLE 440: Brazil point of care testing market size, by product, 2018 - 2024 (USD Million)
  • TABLE 441: Brazil point of care testing market size, by glucose monitoring, 2013 - 2017 (USD Million)
  • TABLE 442: Brazil point of care testing market size, by glucose monitoring, 2018 - 2024 (USD Million)
  • TABLE 443: Brazil point of care testing market size, by cardiometabolic testing products, 2013 - 2017 (USD Million)
  • TABLE 444: Brazil point of care testing market size, by cardiometabolic testing products, 2018 - 2024 (USD Million)
  • TABLE 445: Brazil point of care testing market size, by infectious disease testing products, 2013 - 2017 (USD Million)
  • TABLE 446: Brazil point of care testing market size, by infectious disease testing products, 2018 - 2024 (USD Million)
  • TABLE 447: Brazil point of care testing market size, by coagulation testing products, 2013 - 2017 (USD Million)
  • TABLE 448: Brazil point of care testing market size, by coagulation testing products, 2018 - 2024 (USD Million)
  • TABLE 449: Brazil point of care testing market size, by pregnancy and fertility testing products, 2013 - 2017 (USD Million)
  • TABLE 450: Brazil point of care testing market size, by pregnancy and fertility testing products, 2018 - 2024 (USD Million)
  • TABLE 451: Brazil point of care testing market size, by technology, 2013 - 2017 (USD Million)
  • TABLE 452: Brazil point of care testing market size, by technology, 2018 - 2024 (USD Million)
  • TABLE 453: Brazil point of care testing market size, by prescription, 2013 - 2017 (USD Million)
  • TABLE 454: Brazil point of care testing market size, by prescription, 2018 - 2024 (USD Million)
  • TABLE 455: Brazil point of care testing market size, by application, 2013 - 2017 (USD Million)
  • TABLE 456: Brazil point of care testing market size, by application, 2018 - 2024 (USD Million)
  • TABLE 457: Brazil point of care testing market size, by end-use, 2013 - 2017 (USD Million)
  • TABLE 458: Brazil point of care testing market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 459: Mexico point of care testing market size, by product, 2013 - 2017 (USD Million)
  • TABLE 460: Mexico point of care testing market size, by product, 2018 - 2024 (USD Million)
  • TABLE 461: Mexico point of care testing market size, by glucose monitoring, 2013 - 2017 (USD Million)
  • TABLE 462: Mexico point of care testing market size, by glucose monitoring, 2018 - 2024 (USD Million)
  • TABLE 463: Mexico point of care testing market size, by cardiometabolic testing products, 2013 - 2017 (USD Million)
  • TABLE 464: Mexico point of care testing market size, by cardiometabolic testing products, 2018 - 2024 (USD Million)
  • TABLE 465: Mexico point of care testing market size, by infectious disease testing products, 2013 - 2017 (USD Million)
  • TABLE 466: Mexico point of care testing market size, by infectious disease testing products, 2018 - 2024 (USD Million)
  • TABLE 467: Mexico point of care testing market size, by coagulation testing products, 2013 - 2017 (USD Million)
  • TABLE 468: Mexico point of care testing market size, by coagulation testing products, 2018 - 2024 (USD Million)
  • TABLE 469: Mexico point of care testing market size, by pregnancy and fertility testing products, 2013 - 2017 (USD Million)
  • TABLE 470: Mexico point of care testing market size, by pregnancy and fertility testing products, 2018 - 2024 (USD Million)
  • TABLE 471: Mexico point of care testing market size, by technology, 2013 - 2017 (USD Million)
  • TABLE 472: Mexico point of care testing market size, by technology, 2018 - 2024 (USD Million)
  • TABLE 473: Mexico point of care testing market size, by prescription, 2013 - 2017 (USD Million)
  • TABLE 474: Mexico point of care testing market size, by prescription, 2018 - 2024 (USD Million)
  • TABLE 475: Mexico point of care testing market size, by application, 2013 - 2017 (USD Million)
  • TABLE 476: Mexico point of care testing market size, by application, 2018 - 2024 (USD Million)
  • TABLE 477: Mexico point of care testing market size, by end-use, 2013 - 2017 (USD Million)
  • TABLE 478: Mexico point of care testing market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 479: Middle East and Africa point of care testing market size, by country, 2013 - 2017 (USD Million)
  • TABLE 480: Middle East and Africa point of care testing market size, by country, 2018 - 2024 (USD Million)
  • TABLE 481: Middle East and Africa point of care testing market size, by product, 2013 - 2017 (USD Million)
  • TABLE 482: Middle East and Africa point of care testing market size, by product, 2018 - 2024 (USD Million)
  • TABLE 483: Middle East and Africa point of care testing market size, by glucose monitoring, 2013 - 2017 (USD Million)
  • TABLE 484: Middle East and Africa point of care testing market size, by glucose monitoring, 2018 - 2024 (USD Million)
  • TABLE 485: Middle East and Africa point of care testing market size, by cardiometabolic testing products, 2013 - 2017 (USD Million)
  • TABLE 486: Middle East and Africa point of care testing market size, by cardiometabolic testing products, 2018 - 2024 (USD Million)
  • TABLE 487: Middle East and Africa point of care testing market size, by infectious disease testing products, 2013 - 2017 (USD Million)
  • TABLE 488: Middle East and Africa point of care testing market size, by infectious disease testing products, 2018 - 2024 (USD Million)
  • TABLE 489: Middle East and Africa point of care testing market size, by coagulation testing products, 2013 - 2017 (USD Million)
  • TABLE 490: Middle East and Africa point of care testing market size, by coagulation testing products, 2018 - 2024 (USD Million)
  • TABLE 491: Middle East and Africa point of care testing market size, by pregnancy and fertility testing products, 2013 - 2017 (USD Million)
  • TABLE 492: Middle East and Africa point of care testing market size, by pregnancy and fertility testing products, 2018 - 2024 (USD Million)
  • TABLE 493: Middle East and Africa point of care testing market size, by technology, 2013 - 2017 (USD Million)
  • TABLE 494: Middle East and Africa point of care testing market size, by technology, 2018 - 2024 (USD Million)
  • TABLE 495: Middle East and Africa point of care testing market size, by prescription, 2013 - 2017 (USD Million)
  • TABLE 496: Middle East and Africa point of care testing market size, by prescription, 2018 - 2024 (USD Million)
  • TABLE 497: Middle East and Africa point of care testing market size, by application, 2013 - 2017 (USD Million)
  • TABLE 498: Middle East and Africa point of care testing market size, by application, 2018 - 2024 (USD Million)
  • TABLE 499: Middle East and Africa point of care testing market size, by end-use, 2013 - 2017 (USD Million)
  • TABLE 500: Middle East and Africa point of care testing market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 501: South Africa point of care testing market size, by product, 2013 - 2017 (USD Million)
  • TABLE 502: South Africa point of care testing market size, by product, 2018 - 2024 (USD Million)
  • TABLE 503: South Africa point of care testing market size, by glucose monitoring, 2013 - 2017 (USD Million)
  • TABLE 504: South Africa point of care testing market size, by glucose monitoring, 2018 - 2024 (USD Million)
  • TABLE 505: South Africa point of care testing market size, by cardiometabolic testing products, 2013 - 2017 (USD Million)
  • TABLE 506: South Africa point of care testing market size, by cardiometabolic testing products, 2018 - 2024 (USD Million)
  • TABLE 507: South Africa point of care testing market size, by infectious disease testing products, 2013 - 2017 (USD Million)
  • TABLE 508: South Africa point of care testing market size, by infectious disease testing products, 2018 - 2024 (USD Million)
  • TABLE 509: South Africa point of care testing market size, by coagulation testing products, 2013 - 2017 (USD Million)
  • TABLE 510: South Africa point of care testing market size, by coagulation testing products, 2018 - 2024 (USD Million)
  • TABLE 511: South Africa point of care testing market size, by pregnancy and fertility testing products, 2013 - 2017 (USD Million)
  • TABLE 512: South Africa point of care testing market size, by pregnancy and fertility testing products, 2018 - 2024 (USD Million)
  • TABLE 513: South Africa point of care testing market size, by technology, 2013 - 2017 (USD Million)
  • TABLE 514: South Africa point of care testing market size, by technology, 2018 - 2024 (USD Million)
  • TABLE 515: South Africa point of care testing market size, by prescription, 2013 - 2017 (USD Million)
  • TABLE 516: South Africa point of care testing market size, by prescription, 2018 - 2024 (USD Million)
  • TABLE 517: South Africa point of care testing market size, by application, 2013 - 2017 (USD Million)
  • TABLE 518: South Africa point of care testing market size, by application, 2018 - 2024 (USD Million)
  • TABLE 519: South Africa point of care testing market size, by end-use, 2013 - 2017 (USD Million)
  • TABLE 520: South Africa point of care testing market size, by end-use, 2018 - 2024 (USD Million)
  • TABLE 521: Saudi Arabia point of care testing market size, by product, 2013 - 2017 (USD Million)
  • TABLE 522: Saudi Arabia point of care testing market size, by product, 2018 - 2024 (USD Million)
  • TABLE 523: Saudi Arabia point of care testing market size, by glucose monitoring, 2013 - 2017 (USD Million)
  • TABLE 524: Saudi Arabia point of care testing market size, by glucose monitoring, 2018 - 2024 (USD Million)
  • TABLE 525: Saudi Arabia point of care testing market size, by cardiometabolic testing products, 2013 - 2017 (USD Million)
  • TABLE 526: Saudi Arabia point of care testing market size, by cardiometabolic testing products, 2018 - 2024 (USD Million)
  • TABLE 527: Saudi Arabia point of care testing market size, by infectious disease testing products, 2013 - 2017 (USD Million)
  • TABLE 528: Saudi Arabia point of care testing market size, by infectious disease testing products, 2018 - 2024 (USD Million)
  • TABLE 529: Saudi Arabia point of care testing market size, by coagulation testing products, 2013 - 2017 (USD Million)
  • TABLE 530: Saudi Arabia point of care testing market size, by coagulation testing products, 2018 - 2024 (USD Million)
  • TABLE 531: Saudi Arabia point of care testing market size, by pregnancy and fertility testing products, 2013 - 2017 (USD Million)
  • TABLE 532: Saudi Arabia point of care testing market size, by pregnancy and fertility testing products, 2018 - 2024 (USD Million)
  • TABLE 533: Saudi Arabia point of care testing market size, by technology, 2013 - 2017 (USD Million)
  • TABLE 534: Saudi Arabia point of care testing market size, by technology, 2018 - 2024 (USD Million)
  • TABLE 535: Saudi Arabia point of care testing market size, by prescription, 2013 - 2017 (USD Million)
  • TABLE 536: Saudi Arabia point of care testing market size, by prescription, 2018 - 2024 (USD Million)
  • TABLE 537: Saudi Arabia point of care testing market size, by application, 2013 - 2017 (USD Million)
  • TABLE 538: Saudi Arabia point of care testing market size, by application, 2018 - 2024 (USD Million)
  • TABLE 539: Saudi Arabia point of care testing market size, by end-use, 2013 - 2017 (USD Million)
  • TABLE 540: Saudi Arabia point of care testing market size, by end-use, 2018 - 2024 (USD Million)

Charts & Figures

  • FIG. 1: Industry segmentation
  • FIG. 2: Global point of care testing market, 2013 - 2024 (USD Million)
  • FIG. 3: Growth potential analysis, by product
  • FIG. 4: Growth potential analysis, by technology
  • FIG. 5: Growth potential analysis, by prescription
  • FIG. 6: Growth potential analysis, by application
  • FIG. 7: Growth potential analysis, by end-use
  • FIG. 8: Global market share analysis, 2017
  • FIG. 9: Company share analysis, 2017 - North America
  • FIG. 10: Company share analysis, 2017 - Europe
  • FIG. 11: Company share analysis, 2017 - Asia Pacific
  • FIG. 12: Company share analysis, 2017 - Latin America
  • FIG. 13: Company share analysis, 2017 - Middle East and Africa
  • FIG. 14: Porter's analysis
  • FIG. 15: Global company market share analysis, 2017
  • FIG. 16: Strategy dashboard
  • FIG. 17: PESTEL analysis
Back to Top